Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
US biotech viewed as lucrative target partly because of its promising pipeline of weight-loss drugs Novo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Metsera that could gazump an existing bid from Pfizer as the pharmaceutical giants fight for (…)
Site référencé:
The Guardian
5600.jpg?width=140&quality=85&auto=format&fit=max&s=3c9fbe44095ac082c7d3ab69690c3997, 5600.jpg?width=460&quality=85&auto=format&fit=max&s=cfb59dc39e88893fa40a3c4f100554b7, 5600.jpg?width=700&quality=85&auto=format&fit=max&s=a68123dfb611648b76cc65a9b7551f47
The Guardian
India v Australia : Women’s Cricket World Cup semi-final – live
30/10/2025
Hurricane Melissa leaves 29 dead as category 2 storm heads towards Bermuda – live
30/10/2025
Theft by Abdulrazak Gurnah audiobook review – coming-of-age saga in Tanzania
30/10/2025
The best toys and gifts for newborns and babies, from squishy books to sensory sets
30/10/2025
‘It’s dark in the US right now. But I turn on a light, you know ?’ : Mavis Staples on Prince, Martin Luther King and her 75-year singing career
30/10/2025
A third of people in England believe in ghosts, survey finds
30/10/2025